Russell Cynthia L, Gotham Heather J, Cheng An-Lin, Sahil Suman, Yerram Preethi
School of Nursing and Health Studies, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.
Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, 1520 Page Mill Road, Palo Alto, CA 94393, USA.
Int J Nephrol. 2022 Jun 10;2022:9653847. doi: 10.1155/2022/9653847. eCollection 2022.
To explore the relationship between determinants and posttransplant medication nonadherence (MNA) in adult kidney transplant recipients, and to examine the relationship between posttransplant MNA and clinical outcomes.
Using the World Health Organization's model, this retrospective, multicenter, correlational study examined the relationship between determinants, posttransplant MNA, and clinical outcomes in 16,671 adult kidney transplant recipients from the Cerner national data warehouse.
With 12% MNA, those who were nonadherent were more likely to have the social/economic factors of being younger, single, Caucasian versus Hispanic race, have the condition-related factor of mental health/substance use disorder, and have the healthcare system-related factor of government/health maintenance organization/managed care insurance (' < 0.05). Bivariate correlations indicated both age (OR = 1.006, =0.01) and mental health or substance use disorder diagnosis (OR = 1.26, =0.04) were significant predictors of MNA. Patients were 0.6% more likely to be medication adherent for each year they increased in age and 26% more likely to be MNA if they were diagnosed with a mental health/substance use disorder. Nonadherent patients were less likely to be readmitted, but more likely to have complications after transplant and medication side effects (' < 0.01).
Using one of the largest samples of adult kidney transplant patients, our findings support the WHO model and move the body of medication adherence intervention research forward by clarifying the importance of focusing interventions not only on the patient but on multilevel determinants. Consistent with previous studies, MNA negatively impacts transplant outcomes.
探讨成年肾移植受者的决定因素与移植后用药依从性(MNA)之间的关系,并研究移植后MNA与临床结局之间的关系。
采用世界卫生组织的模型,这项回顾性、多中心、相关性研究考察了来自Cerner国家数据仓库的16671例成年肾移植受者的决定因素、移植后MNA和临床结局之间的关系。
MNA发生率为12%,不依从者更有可能具有以下社会/经济因素:年龄较小、单身、白种人与西班牙裔种族相比;具有心理健康/物质使用障碍这一病情相关因素;以及具有政府/健康维护组织/管理式医疗保险这一医疗系统相关因素(P<0.05)。双变量相关性表明年龄(OR = 1.006,P = 0.01)和心理健康或物质使用障碍诊断(OR = 1.26,P = 0.04)均为MNA的显著预测因素。患者年龄每增加一岁,用药依从的可能性增加0.6%,而如果被诊断患有心理健康/物质使用障碍,MNA的可能性增加26%。不依从的患者再次入院的可能性较小,但移植后发生并发症和出现药物副作用的可能性较大(P<0.01)。
通过使用最大规模的成年肾移植患者样本之一,我们的研究结果支持了世界卫生组织的模型,并通过阐明不仅关注患者而且关注多层次决定因素的干预措施的重要性,推动了用药依从性干预研究的发展。与先前的研究一致,MNA对移植结局有负面影响。